ATC Group: N01AH Opioid anesthetics

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of N01AH in the ATC hierarchy

Level Code Title
1 N Nervous system
2 N01 Anesthetics
3 N01A Anesthetics, general
4 N01AH Opioid anesthetics

Group N01AH contents

Code Title
N01AH01 Fentanyl
N01AH02 Alfentanil
N01AH03 Sufentanil
N01AH04 Phenoperidine
N01AH05 Anileridine
N01AH06 Remifentanil
N01AH51 Fentanyl, combinations

Active ingredients in N01AH

Active Ingredient Description
Alfentanil

Alfentanil is a short-acting, synthetic, agonist at mu opioid receptors, used for anaesthesia in surgery.

Anileridine

Anileridine is an opioid receptor agonist belonging to the piperidine class with analgesic activity. By binding to and activating opioid receptors in the central nervous sytem (CNS), anileridine mimics the endogenous opioids resulting in a decrease of nociceptive neurotransmitters and eventually an analgesic effect. Anileridine is useful for the relief of moderate to severe pain. It may also be used as an analgesic adjunct in general anesthesia in the same manner as meperidine to reduce the amount of anesthetic needed, to facilitate relaxation, and to reduce laryngospasm. In addition, anileridine exerts mild antihistaminic, spasmolytic and antitussive effects.

Fentanyl

Fentanyl is a potent ยต-opioid analgesic with rapid onset of analgesia and short duration of action. Its primary therapeutic actions are analgesia and sedation and is approximately 100-fold more potent than morphine as an analgesic. Secondary effects of fentanyl on central nervous system (CNS), respiratory and gastro-intestinal function are typical of opioid analgesics and are considered to be class effects.

Phenoperidine

Phenoperidine is an opioid analgesic which is structurally related to pethidine (derivative of isonipecotic acid) and is used clinically as a general anesthetic.

Remifentanil

Remifentanil is a selective mu-opioid agonist with a rapid onset and very short duration of action. The mu-opioid activity, of remifentanil, is antagonised by narcotic antagonists, such as naloxone.

Sufentanil

Sufentanil is a synthetic opioid analgesic drug approximately 5 to 10 times as potent as its parent drug, fentanyl, and 500 times as potent as morphine. Structurally, sufentanil differs from fentanyl through the addition of a methoxymethyl group on the piperidine ring (which is believed to reduce duration of action), and the replacement of the phenyl ring by thiophene. The main use of this medication is in operating suites and critical care where pain relief is required for a short period of time. It also offers properties of sedation and this makes it a good analgesic component of anesthetic regimen during an operation

Related product monographs

Title Information Source Document Type  
ALFENTANIL Solution for injection Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
DZUVEO Sublingual tablet European Medicines Agency (EU) MPI, EU: SmPC
FENTANYL Solution for injection Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
FORTIVA Solution for injection Health Products Regulatory Authority (ZA) MPI, Generic
MATRIFEN Transdermal patch Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
Rapifen 500 micrograms/ml solution for injection or infusion Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
SOFENTIL Solution for injection / infusion Web Search MPI, EU: SmPC
SUBLIMAZE Solution for injection Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
SUFENTA Solution for injection / infusion Health Products Regulatory Authority (ZA) MPI, Generic
ULTIVA Powder for concentrate for solution for infusion Health Products Regulatory Authority (IE) MPI, EU: SmPC
ZALVISO Sublingual tablet European Medicines Agency (EU) MPI, EU: SmPC